Works matching IS 13524585 AND DT 2017 AND VI 23 AND IP 5
Results: 19
Primary and secondary progressive MS have a similar age at onset of progression - Commentary.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 642, doi. 10.1177/1352458517697378
- By:
- Publication type:
- Article
The most frequently asked question to a statistician: The sample size.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 644, doi. 10.1177/1352458517695471
- By:
- Publication type:
- Article
Peripheral nervous system involvement in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 751, doi. 10.1177/1352458517693469
- By:
- Publication type:
- Article
The measure tells the tale: Clinical outcome measures in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 626, doi. 10.1177/1352458517690825
- By:
- Publication type:
- Article
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 711, doi. 10.1177/1352458517690824
- By:
- Publication type:
- Article
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 704, doi. 10.1177/1352458517690823
- By:
- Publication type:
- Article
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 734, doi. 10.1177/1352458517690822
- By:
- Publication type:
- Article
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 721, doi. 10.1177/1352458517690821
- By:
- Publication type:
- Article
Primary and secondary progressive MS have a similar age at onset of progression - YES.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 638, doi. 10.1177/1352458517690273
- By:
- Publication type:
- Article
Data quality evaluation for observational multiple sclerosis registries.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 647, doi. 10.1177/1352458516662728
- By:
- Publication type:
- Article
Primary and secondary progressive MS have a similar age at onset of progression - NO.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 640, doi. 10.1177/1352458516684559
- By:
- Publication type:
- Article
Breaking down the gut microbiome composition in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 628, doi. 10.1177/1352458516682105
- By:
- Publication type:
- Article
Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 665, doi. 10.1177/1352458516663034
- By:
- Publication type:
- Article
Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 696, doi. 10.1177/1352458516663033
- By:
- Publication type:
- Article
Involvement of peripheral III nerve in multiple sclerosis patient: Report of a new case and discussion of the underlying mechanism.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 686, doi. 10.1177/1352458516662727
- By:
- Publication type:
- Article
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 675, doi. 10.1177/1352458516661048
- By:
- Publication type:
- Article
Removal Notice.
- Published in:
- 2017
- Publication type:
- Correction Notice
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 656, doi. 10.1177/1352458516659550
- By:
- Publication type:
- Article